This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (20)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Psychiatry  • Alert me on articles by topic

Jimmy Dy Chua, MD; William R. Friedenberg, MD

Arch Intern Med. 1998;158:1929-1932.

Background  Superwarfarin sodium exposure or poisoning is a growing public health problem. There were 5133 reported cases of superwarfarin exposure and poisoning in 1988 and 13423 cases in 1995. Cases may be associated with accidental exposure, suicide attempts, or Munchausen syndrome, and may be difficult to diagnose.

Patients and Methods  Patients from northern Wisconsin with superwarfarin exposure or poisoning were examined at a tertiary referral center in rural Wisconsin to determine what led to their exposure and to review the clinical manifestations, diagnosis, treatment, and prevention of superwarfarin poisoning.

Results  Eleven cases satisfied the criteria for superwarfarin exposure or poisoning. All 7 children included in the study had accidentally ingested superwarfarin, 2 adults had Munchausen syndrome, and 1 teenager and 1 adult had attempted suicide using superwarfarin. Nine of the 11 cases had taken brodifacoum. The patients who had accidentally ingested superwarfarin or attempted suicide using it were easily diagnosed, while diagnosis was markedly delayed for the 2 patients with Munchausen syndrome. Full reversal of anticoagulation was quickly achieved in the cases of accidental ingestion and attempted suicide. We examined and treated the patients with Munchausen syndrome for months before establishing a diagnosis and fully reversing the anticoagulation. None of the patients in our study died of superwarfarin poisoning.

Conclusions  Superwarfarin exposure or poisoning is a growing public health problem that should be part of the differential diagnosis of patients who present with a coagulopathy consistent with vitamin K deficiency in the absence of coumadin therapy, liver disease, or the use of an inhibitor, and whose conditions do not resolve with large doses of parenteral vitamin K₁ therapy.

From the Marshfield Clinic, Marshfield, Wis. Dr Chua is now with the Cleveland Clinic Foundation, Cleveland, Ohio.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Case of the month: "Oh! Drat!--A case of transcutaneous superwarfarin poisoning and its recurrent presentation"
Binks and Davies
Emerg. Med. J. 2007;24:307-308.
ABSTRACT | FULL TEXT  

Case 1-2007 -- A 40-Year-Old Woman with Epistaxis, Hematemesis, and Altered Mental Status
Laposata et al.
NEJM 2007;356:174-182.
FULL TEXT  

A 44-Year-Old Woman With Hematemesis and Cutaneous Hemorrhages as a Result of Superwarfarin Poisoning
Dolin et al.
JAOA: Journal of the American Osteopathic Association 2006;106:280-284.
ABSTRACT | FULL TEXT  

Prolonged Coagulopathy Related to Superwarfarin Overdose
Sarin et al.
ANN INTERN MED 2005;142:156-156.
FULL TEXT  

Brodifacoum Toxicosis in Two Neonatal Puppies
Munday and Thompson
Vet Pathol 2003;40:216-219.
ABSTRACT | FULL TEXT